Journal of Prevention, Diagnosis and Management of Human Diseases (JPDMHD) ISSN 2799-1202 · Vol. 4, No. 01 (2024) · pp. 103-111
Research Paper

Assessment of some biometrics and biochemical parameters in migraine patients

Faiz Ali Al-Mfrgi1, Maan Hasan Salih2
  1. 1 High diploma in pathoanalysis-Optics Department-College of Health and Medical Techniques-Al-Door -Northern Technical university-Salahaddin-Iraq.
  2. 2 Assist.prof. Doctorate in molecular biology-Biology Department-Science College-Tikrit University- Salahaddin -Iraq.
  3. * Corresponding author: Faiz Ali Al-Mfrgi, Faizaliahmed2020@gmail.com
Received20 December 2023
Revised6 March 2024
Accepted12 March 2024
Published29 April 2024
DOIhttps://doi.org/10.55529/jpdmhd.43.9.17
LicenceCC BY 4.0
PDFDownload PDF

Abstract

Background: Migraine is a pulsating and recurrent headache in one or both side. It may be caused by induce of nerves in the brain blood vessels walls and its associates with photophobia. Objectives: Measure of Body mass index (BMI), blood pressure (BP), serum calcium (Ca), magnesium (Mg) and iron (Fe) in migraine patients. Methods: This study performed on 94 persons (64 migraine: 30 control), who visited Al-Duloya General Hospital, Tikrit Educational Hospital, and neurological clinics in Al-Duloya and Tkrit. Also it contains visiting participants to their homes in Salahaddin in Iraq. A socio-demographic characters, length, weight, and BP taken directly. 3-5ml blood sampled for obtaining serum. Biochemical tests analyzed by spectrophotometer in Central laboratory of Tikrit University. The study period extended from 30-7-2023 to 27-9-2023. GraphPrism9 program and T-test used for statistical analysis. Results: Patient age was 34.9(16-63) year. Higher percentages reported in female (79.6%) and family history (68.7%). BMI (29.1±5.5), (27.6±5.3) kg/m2, systolic BP (11.7±1.2), (11.5±1.1), and diastolic BP (7.5±0.8), (7.2±1.0) Cm.Hg, show non-significant elevation in migraine compare with control respectively. Mg reveals significant decrease (1.7±0.7), (2.1±0.6), but Ca (7±0.5), (7.3±0.7) and Iron (82±57), (90±52) mg/dL reveal non-significant decrease in migraine compare with control respectively. Conclusions: BMI and BP show non-significant elevation. While Mg reveals significant decrease, Ca and Iron reveal non-significant decrease in patients.

Keywords: Migraine; Serum Minerals; Blood Pressure; Body Mass Index; Iron

1. INTRODUCTION

Headache affects 16% of people around the world every day [1]. It affects social, health and other conditions3. Migraine is intermitted, frequented and pulsating pain attacks that occur in one side of head. It result from stimulation of nervous fibers of blood vessel walls in the brain cover membranes [2]. Disease manifestations contain phonophobia and numbness [3]. It may complicates to brain failure [4]. Migraine types are migraine with aura, migraine without aura, silent migraine (without headache) and abdominal migraine (abdominal pain in children) [5]. This disease trigged by pregnancy, menstruation, industrial foods, drugs, fasting, stress, odors, sleep disturbance and climate changes. Its causes are unknown, but it is believed to be a temporary defect in nerve and biochemical signals and brain blood vessels [3]. There are 123 loci associate with migraine [6]. Diagnosis includes medical and family history, clinical investigation, and magnetic resonance imaging (MRI) [3].

The problem of this disease is lack of laboratory or other test, but it is diagnosed according to patient condition [7]. The prevalence of migraine is 14% globally [1], (2.6-32) % in Arabic region [8] and 44% of Iraqi women (18-35) year’s age in Sulaimania province [9]. It prevalent in women more than men, and varies according to race [10]. Biometrics contain body mass index (BMI), that calculated by equation: (BMI = weight / length2). It’s ideal value is (20-25Kg/m2) nearly [11]. It affected by health condition, gender, age and muscular mass. BMI used for classify persons to obese, over weight and normal. By this method we expect a chronic diseases risks such as hypertension, diabetes and cholesterol [12]. Report correlation between obesity and migraine [13]. Blood pressure (BP) is the pressure exerted by blood on the arteries walls [14].

Hypertension is the blood pressure level ≥14/9 Cm.Hg. causes and risk factors of hypertension include congenital malformation in blood vessels, sleep disorders and diabetes. Its complications contain vessel sclerosis and stroke [15]. Report that hypertension is a risk factor for migraine [16]. Biochemical parameters include calcium (Ca), it is a structural element of bones, proteins and phospholipids in cell membranes. It maintains membrane structure, controls its permeability of ions including itself, control nerve irritation, control many enzymes reactions and transfer many hormones to receptor site on cell membrane [17].

2. RELATED WORK

Note that Ca is a migraine risk factor [18]. Magnesium (Mg) acts as an enzyme cofactor for sugar metabolism, there for its decrease causes sugar imbalance [19]. Mg deficiency caused by low intake or high excretion, and it may be as a result of mutation causing migraine attacks [20]. Iron (Fe) is stored in body organs such liver and found in hemoglobin and myoglobin. This proteins transfer O2 to all body parts. Iron deficiency anemia (IDA) is caused by low body storage of Fe, malnutrition, blood loss, digestive malabsorption and pregnancy. IDA also affects children [21]. Found correlation between IDA and migraine [22]. Objectives: Because migraine causes are unknown, and there are not laboratory or other tests for it, the current study came to investigate some biometrics and biochemical variables, including: BMI, BP, Ca, Mg, and Fe, that may be used as a biomarkers specific for migraine [23].

3. METHODOLOGY

Materials and methods: Patients and methods: An analytical descriptive cross sectional study performed on 94 individuals (64 patients and 30 control), who visited Al-Duloya General Hospital, Clinic of Dr. Uqba Al-Jubori in Al-Duloya , Tikrit Educational Hospital, and Clinic of Dr. Abd-Al-Sattar Al-Jubori in Tkrit in Salahaddin Province in Iraq. Also it includes visiting participants in their homes in Al-Duloya. Control includes (15male:15 female). Socio-demographic characters taken by questionnaire. BMI (BMI=weight/length2) [11] and BP reported directly. 3-5ml of venous blood sampled. It left for several minutes then centrifuged 4000 rpm for 15 minutes for obtaining serum. It used for performing biochemical tests that included Ca (BioResearch kit Jordan), Mg (Agappe kit Indian) and Iron (Biolab French). Spectrophotometer used in Central laboratory of Tikrit University. The period of study extended from 30- 7-2023 to 27-9-2023. Inclusion criteria: Migraine patients (headache migraine) of all ages, both genders and at all stages of the disease.

Exclusion criteria: Abdominal migraine patients were excluded, because the current study targeted headache migraine patients, who visited neurologists rather than abdominal migraine, who visited internal medicine doctors. Ethical approval: The ethics committee of the Science College in University of Tikrit in Iraq agree this study. Written agreements reported, signed and date taken from participants in this study. Statistical analysis: T-test and GraphPrism9 program used for statistical analysis at (P≤0.05). Mean (M) and standard deviation (SD) calculated for quantitative variables and percentage for qualitative parameters. 5)

4. RESULTS AND DISCUSSION

Results Socio-demographic characters: Table 1 reveals socio-demographic characters of patients. Mean and range of age are 34.9(16-63) year. Mean age of them falls into adulthood, and its deviation is high; i.e. migraine widespread at most ages. Same Table 1 reveals that male 20.3%, female 79.6% and family history of disease (migraine in relatives) 68.7%. Female have higher percentage than male, and most patients have family history of migraine.

Table 1. Socio-Demographic Characters of Migraine Patients
Table 1

Biometrics: BMI of migraine and control is shown in Table 2. It reveals non-significant increase in migraine (29.1±5.5) compare with control (27.6±5.3) kg/m2. Table 2 also reveals BP in migraine and control. It reports non-significant increase in BP in migraine compare with control: systolic (11.7±1.2), (11.5±1.1), diastolic (7.5±0.8), (7.2±1.0) Cm.Hg respectively.

Table 2. Biometrics (Body Mass Index and Blood Pressure) of Migraine Patients and Control
Table 2
Figure 1
Figure 1. Reveals Serum Ca Levels in Migraine Patients and Control
Figure 2
Figure 2. Reveals Serum Mg Levels in Migraine and Control

It reports significant decrease in migraine (1.7±0.7) compare with control (2.1±0.6) mg/dL. (1.7±0.7) (2.1±0.6). Figure 2. Magnesium Levels (Mg) in Migraine Patients and Control. (T-test used at P-

Figure 3
Figure 3. Reveals Serum Iron Levels in Migraine and Control

It reports non-significant decrease in iron in migraine patients (82±57), compare with control (90±52) mg/dL. (82±57) (90±52) Figure 3. Iron (Fe) levels in migraine patients and control. (T-test used at P-value: 0.05)

Discussion

Socio-demographic characters: Migraine reported at most ages. This disease trigged by many factors including: stress, concentrated odors, sleep disorders and climate changes [3]. This may be the reason for its widespread in most ages. This results agree with Tarkh and Khalaf study, (2019) in Iraq, which founds that age is 32 (15-60) years. The cause of high percentage in female is the correlation of disease with female hormone and menstrual cycle [24]. Note that female in reproductive age have significant high level of CGRP [25]. This peptide correlated with female hormones [26]. It is active vasodilator, trigger for migraine attack and stimulated during it. It has role in headache [27]. This results align with who reported that female percentage is 73 % [28]. One of risk factors of migraine is family history [3]. Aljobory, (2021) founds that a percentage of relative marriage in Salahaddin Province is 59.2%. It resulting from prevailing traditions. He also founds that genetic disease represent 68.1% of offspring of this marriage type [29]. This study parallel with who note that family history represents 53% [30]. Biometrics: Genetic, environment and manner factors cause obesity such as mutations, disease family history [31] high sugar and fat food and less exercise [32]. This result aligns with results who report BMI elevation in migraine compare with control [33], [34].

The cause and risk factors of hypertension are congenital malformation in blood vessels, gender and psycho stress. Hypertension results vasodilation [15]. Report that ˃ 50% of migraine patients have hypertension [35]. Found decrease in systolic BP but increase in diastolic BP in migraine [36]. CGRP gene correlates with migraine, it coding for CGRP peptide receptor [37]. This peptide is vasodilator secreted by trigeminal nerves, and interfere with migraine pathogenesis [38]. Biochemical parameters: The causes of Ca decrease are failure of parathyroid hormone secretion that control Ca and imbalance of vitamin D metabolism [39]. This result agrees with results who found decrease of Ca in migraine [40] but differs from Alzubaidy (2019) who reveals significant elevation [41]. ATP1A2 gene coding for protein from ATPase family that contribute in positive ion balance and electrochemical variety of it. It is correlates with electrical irritation of nerves and muscles. Mutation in this gene may results some forms of migraine [42]. Mg decease may be results from low intake and high loss by digestive system or kidney causing migraine attacks [20]. Found mutation in TRPM7 gene, that control Mg balance then causing migraine attacks [43]. Mg decrease causes imbalance of other ions. This may be causes muscular nervous symptoms [44]. This result agrees with who found significant decrease of Mg in patients [45] but differs from who report elevation in Saudian migraine patients [33]. A risk factors of IDA include food intake pattern, female gender, parasites, low teaching level, low income, female aging [46] and menstruation (causes headache) [47]. This study agrees with who note that IDA was a common problem in migraine young females [48]. Found increase of migraine risk in IDA patients [49], [50], [51].

5. CONCLUSION

BMI and BP reveal non-significant increase in migraine compare with control. Mg reveals significant decrease, while Ca and Iron reveal non-significant decrease in migraine compare with control. Future prospective: Investigate correlations among biometrics, biochemical, gene expression and mutations causing migraine. Limitations: It includes lack of cooperation from some neurologists in the sampling process, some patients refrain from giving the sample and lack of laboratory training lessons and other statistical analysis lessons in ready-made programs in the study plan in the preparatory year. Knowledgement: Thanks for professionals in Central Laboratory in Tikrit University, especially Dr. Mohammed M., Dr. Shaimaa A. and Mr. Riath Al-Dori, for their contribution in experimental part. Thanks for neurologists, lab. technicians and training chairmen in Al-Duloya general hospital, Tikrit teaching hospital and Balad general hospital, for their contributions in sampling, especially Dr. Uqba Al-Jubori and Dr. Abd-Al-Sattar Al-Jubori. Finding: No finding was received for conducting this study.

Acknowledgments

The authors have no specific acknowledgments to make for this research.

Funding Information

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author Contributions Statement

Name of AuthorCMSoVaFoIRDOEViSuPFu
Faiz Ali Al-Mfrgi✓✓✓✓✓✓✓✓✓✓✓
Maan Hasan Salih✓✓✓✓✓✓✓✓✓✓

C: Conceptualization; M: Methodology; So: Software; Va: Validation; Fo: Formal analysis; I: Investigation; R: Resources; D: Data curation; O: Writing – original draft; E: Writing – review & editing; Vi: Visualization; Su: Supervision; P: Project administration; Fu: Funding acquisition.

Conflict of Interest Statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Informed Consent

All participants were informed about the purpose of the study, and their voluntary consent was obtained prior to data collection.

Ethical Approval

The study was conducted in compliance with the ethical principles outlined in the Declaration of Helsinki and approved by the relevant institutional authorities.

Data Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. [1] Stovner L, Hagen K, Linde M, and Steiner T. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. The journal of headache and pain. 2022;23, No. 34.https://thejournalofheadacheand pain.biomedcentral.com/articles/10.1186/s10194-022 01402-2. doi.org/10.1186/s10194-022-01402-2
  2. [2] 'Migraine', National Institute of Neurological Disorders and Stroke. [Online]. Available: https://www.ninds.nih.gov/health-information/disorders/migraine. [Accessed: 11-Feb-2026]
  3. [3] Ministry of Health- Saudia Arabia. Nervous system disease-migraine. 1440. Moh.gov.sa
  4. [4] ف. ب. و. ال صحة, 'Ministry of health Saudi Arabia', Ministry Of Health Saudi Arabia. [Online]. Available: https://www.moh.gov.sa/en/HealthAwareness/EducationalContent/Diseases/Nervoussystem/Pages/Migraine.aspx. [Accessed: 11-Feb-2026]
  5. [5] Foster E. Migraine. Migraine and Headache Australia Organization. 2021.
  6. [6] American migraine Foundation, (2023), What type of headache do you have?,https://americanmigrainefoundation.org
  7. [7] Hautakangas H., Pirinen M. Genome wide analysis of 102084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nature genetics. 2022; 54, 152-160
  8. [8] Ministry of Health in Lebanon. National Awareness for migraine. 2019. https://ww w.moph.gov.lb
  9. [9] A. El-Metwally, 'The epidemiology of migraine headache in Arab countries: A systemic review', The scientific world journal, vol. 2020. doi.org/10.1155/2020/4790254
  10. [10] D. T. Khafaf and B. Meral Koç, 'Epidemiology of migraines in Iraqi females: Emphasis on dietary influence', Cureus, vol. 15, no. 8, p. e44080, Aug. 2023. doi.org/10.7759/cureus.44080
  11. [11] Simmonds L, Mehta D, Cheema S and Matharu M. Epidemiology of migraine. Hand book of clinical neurology. 2023; 198: p. 31-38.https:://doi.org/10.1016/B978-0-12823356-6.00017-2 doi.org/10.1016/B978-0-12-823356-6.00017-2
  12. [12] CDC, 'Centers for disease control and prevention', 06-Feb-2026. [Online]. Available: https://www.cdc.gov. [Accessed: 11-Feb-2026]
  13. [13] D. Khanna, C. Peltzer, P. Kahar, and M. Parmar, 'Body mass index (BMI): A screening tool analysis', Review. Cures, vol. 14, no. 2, 2022. doi.org/10.7759/cureus.22119
  14. [14] S. Jahromi, F. Martami, K. Soltani, and M. Togha, 'Migraine and obesity: what is the real direction of their association?', vol. 23, pp. 75-84, Jan. 2022. doi.org/10.1080/14737175.2023.2173575
  15. [15] S. R. Jahromi, F. Martami, K. Morad Soltani, and M. Togha, 'Migraine and obesity: what is the real direction of their association?', Expert Rev. Neurother., vol. 23, no. 1, pp. 75-84, Jan. 2023. doi.org/10.1080/14737175.2023.2173575
  16. [16] CDC, 'High blood pressure', High Blood Pressure, 14-Feb-2025. [Online]. Available: https://www.cdc.gov/bloodpressure/. [Accessed: 11-Feb-2026]
  17. [17] 'Request Rejected'. [Online]. Available: https://www.moh.gov.sa. [Accessed: 11-Feb-2026]
  18. [18] S. Suderhan, A. Sudershan, and K. Singh, Migraine and insulin metabolism linked with glutamate excitotoxicity, vol. 8. India, 2022, pp. 1-004.
  19. [19] W. Robertson, 'Chemistry and biochemistry of calcium, Calcium in human biology', pp. 1-26, 2023. doi.org/10.1007/978-1-4471-1437-6_1
  20. [20] P. Yin, V. Anttila, K. M. Siewert, A. Palotie, G. Davey Smith, and B. F. Voight, 'Serum calcium and risk of migraine: a Mendelian randomization study', Hum. Mol. Genet., vol. 26, no. 4, pp. 820-828, Feb. 2017. doi.org/10.1093/hmg/ddw416
  21. [21] M. Aksit, 'The impact of magnesium on the glycemic regulation', Int. J. Med. Biochem., 2018. doi.org/10.14744/ijmb.2018.52724
  22. [22] J. A. Maier, G. Pickering, E. Giacomoni, A. Cazzaniga, and P. Pellegrino, 'Headaches and magnesium: Mechanisms, bioavailability, therapeutic efficacy and potential advantage of magnesium pidolate', Nutrients, vol. 12, no. 9, p. 2660, Aug. 2020. doi.org/10.3390/nu12092660
  23. [23] F. Dasa, 'Factors affecting iron absorption and mitigation mechanisms: A review', IJASFT, 2018. doi.org/10.17352/2455-815X.000033
  24. [24] A. Tayyebi, M. Poursadeghfard, M. Nazeri, and T. Pousadeghfard, 'Is there any correlation between migraine attacks and iron deficiency anemia? A case-control study', Int. J. Hematol. Oncol. Stem Cell Res., vol. 13, no. 3, pp. 164-171, July 2019. doi.org/10.18502/ijhoscr.v13i3.1276
  25. [25] A. Tarkh and A. Khalaf, 'Migraine headache in Shirqat city and the role of some prophylactic drugs', The Med. J. of Tikrit Univer, no. 2, pp. 203-211, 2019.
  26. [26] Ministry of health-Lebanon. Moph.gov.lb. Migraine. 2023.
  27. [27] B. Raffaelli et al., 'Sex hormones and calcitonin gene-related peptide in women with migraine: A cross-sectional, matched cohort study', Neurology, vol. 100, no. 17, pp. e1825-e1835, Apr. 2023. doi.org/10.1212/WNL.0000000000207114
  28. [28] M. Fila, J. Chojnacki, P. Sobczuk, C. Chojnacki, and J. Blasiak, 'Nutrition and calcitonin gene related peptide (CGRP) in migraine', Nutrients, vol. 15, no. 2, p. 289, Jan. 2023. doi.org/10.3390/nu15020289
  29. [29] A. Carmine Belin, C. Ran, and L. Edvinsson, 'Calcitonin gene-related peptide (CGRP) and cluster headache', Brain Sci., vol. 10, no. 1, p. 30, Jan. 2020. doi.org/10.3390/brainsci10010030
  30. [30] D. C. Buse et al., 'Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study', J. Headache Pain, vol. 21, no. 1, p. 23, Mar. 2020. doi.org/10.1186/s10194-020-1084-y
  31. [31] M. Ajobory, Geographical analysis of relative's marriage in the urban of Salahaddin province. Iraq, 2021.
  32. [32] G. Kardes, A. Hadimli, and A. M. Ergenoglu, 'Determination of the frequency of migraine attacks in pregnant women and the ways they cope with headaches: A cross-sectional study', Healthcare (Basel), vol. 11, no. 14, p. 2070, July 2023. doi.org/10.3390/healthcare11142070
  33. [33] National Kidney Foundation. Obesity. 2023. USA. https://www.kidney.org/atoz/content /obesity.
  34. [34] World Health Organization (WHO). Obesity and overweight. 2023. https://www.who.int/newsroom/fact-sheets/detail/obesity-and-overweight
  35. [35] S. Alshehri, F. Alshubaily, A. Alzubidi, H. Sonbol, S. Rahimuddin, and E. Jambi, 'The correlation between migraine and some biochemical parameters in Saudi females', J Biochem Tech, vol. 10, no. 1, pp. 67-71, 2019.
  36. [36] Harder A, Vijfhuizen L, Henneman P, Van Dick K, Van Duijn C, Terwindt G, and Van den Maagdenberg A. Metabolic profile changes in serum of migraine patients detected using H-NMR spectroscopy. The journalof headache and pain. 2021; 22: 142.https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s101940w doi.org/10.1186/s10194-021-01357-w
  37. [37] International journal of advanced research in biological sciences (IJARBS). Darshan Publishers, 2016
  38. [38] Z. Siva et al., 'Determinants of glucose metabolism and the role of NPY the progression of insulin resistance in chronic migraine', Sage journals, 2017. doi.org/10.1177/0333102417748928
  39. [39] CGRP gene, Homo sapiens. Gene, 2023.
  40. [40] M. Fila, A. Sobczuk, E. Pawlowska, and J. Blasiak, 'Epigenetic connection of the calcitonin gene-related peptide and its potential in migraine', Int. J. Mol. Sci., vol. 23, no. 11, p. 6151, May 2022. doi.org/10.3390/ijms23116151
  41. [41] Bove-Fenderson E and Mannstadt M. Hypocalcemic disorder. Best Pract Res Clin Endocinol Metab. 2018; 32(5): 639-656. Doi: 10.1016/j.beem.2018.05.006.Epub 2018 May 28. doi.org/10.1016/j.beem.2018.05.006
  42. [42] Patel U, Kodumuri N, Malik P, Kapoor A, Malhi P, Patel K, Saiyed S, Lovado L, and Kapoor V, Hypocalcemia and vitamin D deficiency amongst migraine patients: A nationwide retrospective study. Medicina. 2019; 55(8), 407; http://do I.org/10.3390/me dicina550804 07. doi.org/10.3390/medicina55080407
  43. [43] A. Alzubaidy, F. Alshubaily, S. Alshehri, H. Sonbol, and S. Rahimuddin, 'The correlation between migraine and some association biomarkers in Saudi females', J biochem Tech, vol. 10, no. 1, pp. 51- 56, 2019.
  44. [44] ATPA1A2 gene, Homo sapiens. Gene, 2023.
  45. [45] M. Lei et al., 'Case report: Recurrent hemilepig migraine attacks accompanied by intractable hypomagnesemia due to ooo', Front Pediatr, vol. 10, 2022. doi.org/10.3389/fped.2022.880242.
  46. [46] G. Liamis, E. Hoorn, M. Florentin, and H. Milionis, 'An overview of diagnosis and management of druginduced hypomagnesemia', vol. 9, 2021. doi.org/10.1002/prp2.829
  47. [47] B. Sundar, A. G, S. M, and T. Iype, 'A study on significance of serum magnesium in migraine', J. Evid. Based Med. Healthc., vol. 4, no. 19, pp. 1102-1107, Mar. 2017. doi.org/10.18410/jebmh/2017/216
  48. [48] M. Wiafe and J. Ayenu, A Review of the risk factors for iron deficiency anemia among aldolescents in developing countries. Hidawi XML groups. 2023. doi.org/10.1155/2023/6406286
  49. [49] American society of hematology organization. Iron deficiency anemia. USA, 2021.
  50. [50] S. Rashid, K. Haq Nawaz, M. H. Athar, A. Fakhar, F. Hakeem, and N. Manzoor, 'Frequency of iron deficiency anemia in young females with migraine', Pak. Armed Force. Med. J., vol. 72, no. SUPPL-2, pp. S371-74, June 2022. doi.org/10.51253/pafmj.v72iSUPPL-2.2977
  51. [51] 'Home page'. [Online]. Available: https://doi.org/. [Accessed: 11-Feb-2026].

How to cite: Faiz Ali Al-Mfrgi, Maan Hasan Salih (2024). Assessment of some biometrics and biochemical parameters in migraine patients. Journal of Prevention, Diagnosis and Management of Human Diseases, 4(01), 103-111. https://doi.org/10.55529/jpdmhd.43.9.17

Copyright © 2024 The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0). Published by HM Publishers.